Program Director: Kevin Kain , MD, FRCPC

  Email Dr. Kain or read about his research.

Learn more about the McLaughlin-Rotman Centre for Global Health Scientists and their research.

The MCMM Global Health Program is known as the McLaughlin-Rotman Centre for Global Health (MRC) due to a generous donation from Mrs. Sandra Rotman to create a centre aspiring to achieve a global reputation in the application of molecular discovery to infectious diseases that impact worldwide. The MRC for Global Health focuses on global infectious disease threats since they are responsible for the greatest burden of illness and death worldwide, account for the most profound disparities in health between the advanced and developing countries, have traditionally been neglected by western research, and can profoundly impact both regional and global economies. The Centre’s mission is to bring together new minds, novel ideas, and innovative solutions to solve problems associated with resurging and emerging infectious disease threats, such as malaria and SARS, respectively. The Centre has three integrated and complementary objectives:
1) to identify the major barriers that prevent the early diagnosis and effective treatment of infectious diseases globally,
2) to elucidate the molecular basis for adverse outcomes for major infectious diseases, and
3) to translate this knowledge in to appropriate technologies and interventions to improve global health.

The centre has initiated a number of projects that are innovative, convergent, and likely to have significant global impact, including:

• Nanotech multiplex diagnostics- simultaneous genomic and proteomic profiling- detection and characterization of multiple pathogens at point-of-care.
• Collaboration with the Structural Genomics Consortium (headed by Dr. Aled Edwards), using genomics and proteomics to identify new drug and vaccine targets for malaria.
• Innate immunity and infectious diseases.
• The development of collaborative overseas research sites and partners.